Board of Scientific Counselors, Office of Public Health Preparedness and Response, (BSC, OPHPR), 13987-13988 [2018-06546]

Download as PDF Federal Register / Vol. 83, No. 63 / Monday, April 2, 2018 / Notices the opioid crisis; (2) Perspectives on, and experiences with, syringe services program (SSP); (3) Continued discussion on HIV transmission risk in the context of Antiretroviral Therapy (ART) use and Viral Suppression (Treatment as Prevention or TasP); (4) Anti-bullying policies in schools; and (5) Updates from Workgroups. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–06547 Filed 3–30–18; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID). This meeting is open to the public, limited only by the space available; the meeting room will accommodate up to 100 people. The public is also welcome to listen to the meeting by telephone, limited only by the number of ports available (50); the toll-free dial-in number is 1–888–998–7892, with a pass code of 1252535. DATES: The meeting will be held on May 2, 2018, 8:30 a.m. to 5:00 p.m., EDT, and May 3, 2018, 8:30 a.m. to 12:00 p.m., EDT. SUMMARY: CDC, Global Communications Center, 1600 Clifton Road NE, Building 19, Auditorium B1/ B2, Atlanta, Georgia 30329; also 1–888– 998–7892. FOR FURTHER INFORMATION CONTACT: Sarah Wiley, MPH, Designated Federal Officer, OID, CDC, 1600 Clifton Road NE, Mailstop D10, Atlanta, Georgia daltland on DSKBBV9HB2PROD with NOTICES ADDRESSES: VerDate Sep<11>2014 19:06 Mar 30, 2018 Jkt 244001 30329, Telephone (404) 639–4840; sed5@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: Strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. Matters To Be Considered: The agenda will include discussions on priority issues for the national centers, including influenza, foodborne infections, antimicrobial resistance, and viral hepatitis, as well as public health workforce development. A report back from the Board’s Infectious Disease Laboratory Working Group will also be given. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–06545 Filed 3–30–18; 8:45 am] BILLING CODE 4163–19–P 13987 only by the room seating. The meeting room accommodates up to 80 people. Public participants should pre-register for the meeting as described below. Members of the public that wish to attend this meeting in person should pre-register by submitting the following information by email, facsimile, or phone (see Contact Person for More Information) no later than 12:00 noon (EDT) on Wednesday, May 2, 2018: • Full Name • Organizational Affiliation • Complete Mailing Address • Citizenship • Phone Number or Email Address The public is also welcome to listen to the meeting by via Adobe Connect. Pre-registration is required by clicking the links below. WEB ID: May 9, 2018 (100 Seats) https://adobeconnect.cdc.gov/ e9teo9x7k41/event/registration.html. WEB ID: May 10, 2018 (100 Seats) https://adobeconnect.cdc.gov/ e2jt3r7tvlj/event/registration.html. Dial in number: 800–857–9618; Participant code: 6838980. (100 Seats). DATES: The meeting will be held on May 9, 2018, 10:00 a.m.–5:30 p.m., EDT and May 10, 2018, 8:30 a.m.–3:30 p.m., EDT. ADDRESSES: Centers for Disease Control and Prevention (CDC), Global Communications Center, Building 19, Auditorium B3, 1600 Clifton Road NE, Atlanta, Georgia 30329. FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Office of Science and Public Health Practice, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop D–44, Atlanta, Georgia 30329, Telephone: (404) 639–7450; Facsimile: (404) 471– 8772; Email: OPHPR.BSC.Questions@ cdc.gov. SUPPLEMENTARY INFORMATION: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Office of Public Health Preparedness and Response, (BSC, OPHPR) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, Office of Public Health Preparedness and Response, (BSC, OPHPR). This meeting is open to the public, limited SUMMARY: PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 Purpose: This Board is charged with providing advice and guidance to the Secretary, Department of Health and Human Services (HHS), the Assistant Secretary for Health (ASH), the Director, Centers for Disease Control and Prevention (CDC), and the Director, Office of Public Health Preparedness and Response (OPHPR), concerning strategies and goals for the programs and research within OPHPR, monitoring the overall strategic direction and focus of the OPHPR Divisions and Offices, and administration and oversight of peer review for OPHPR scientific programs. For additional information about the Board, please visit: https:// www.cdc.gov/phpr/science/ counselors.htm. Matters To Be Considered: The agenda will include discussions on Day one of E:\FR\FM\02APN1.SGM 02APN1 13988 Federal Register / Vol. 83, No. 63 / Monday, April 2, 2018 / Notices the meeting that will cover briefings and BSC deliberation on the following topics: Interval updates from the OPHPR Director and OPHPR Divisions and Offices; updates from the Biological Agent Containment working group; discussion of Industry, Private Sector, and Public Health Interactions Supporting Emergency Preparedness and Response; and Preparedness Updates from Liaison Representatives. Day two of the meeting will cover briefings and BSC deliberation on the following topics: OPHPR Office of Policy, Planning and Evaluation activities; CDC’s Data Preparedness activities; Public Health System Perspectives on Hurricanes Response; and Excellence in Response Operations Initiative. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–06546 Filed 3–30–18; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10191] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of daltland on DSKBBV9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 19:06 Mar 30, 2018 Jkt 244001 this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by June 1, 2018. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs Division of Regulations Development Attention: Document Identifier/OMB Control Number __ Room C4–26–05 7500 Security Boulevard Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ website address at https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork ReductionActof1995/PRA-Listing.html. 2. Email your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov. 3. Call the Reports Clearance Office at (410) 786–1326. FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection’s supporting statement and associated materials (see ADDRESSES). CMS–10191 Medicare Parts C and D Program Audit and Timeliness Monitoring Data Requests Under the PRA (44 U.S.C. 3501– 3520), federal agencies must obtain PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. Information Collection 1. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: Medicare Parts C and D Program Audit and Timeliness Monitoring Data Requests; Use: Medicare Part D plan sponsors and Medicare Advantage organizations (collectively referred to as sponsoring organizations) are required to comply with all Medicare Parts C and D program requirements. In 2010, the explosive growth of these sponsoring organizations precipitated the need for CMS to develop an annual audit strategy to ensure that we evaluate sponsoring organizations compliance with the program requirements. In addition to describing how sponsoring organizations are selected for audit and which program areas will be audited, CMS’ annual audit strategy reflected a move to a more targeted, data-driven, and risk-based audit approach. Since 2010, CMS has continued to focus on assisting the industry with improving their operations to ensure beneficiaries receive appropriate access to care. CMS has developed audit protocols that focus on high-risk areas that have the greatest potential for beneficiary harm. CMS’ program audit protocols are posted to the CMS website each year for use by sponsoring organizations to prepare for their audit. Currently CMS utilizes the following 5 protocols to audit sponsoring organizations’ performance: Compliance Program Effectiveness (CPE), Formulary Administration (FA); Coverage Determinations, Appeals, and Grievances (CDAG); Organization Determinations, Appeals, and Grievances (ODAG), Special Needs Program Model of Care (SNP–MOC) (only administered on organizations who operate SNPs). Beginning in audit E:\FR\FM\02APN1.SGM 02APN1

Agencies

[Federal Register Volume 83, Number 63 (Monday, April 2, 2018)]
[Notices]
[Pages 13987-13988]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-06546]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Public Health 
Preparedness and Response, (BSC, OPHPR)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
Office of Public Health Preparedness and Response, (BSC, OPHPR). This 
meeting is open to the public, limited only by the room seating. The 
meeting room accommodates up to 80 people. Public participants should 
pre-register for the meeting as described below. Members of the public 
that wish to attend this meeting in person should pre-register by 
submitting the following information by email, facsimile, or phone (see 
Contact Person for More Information) no later than 12:00 noon (EDT) on 
Wednesday, May 2, 2018:

 Full Name
 Organizational Affiliation
 Complete Mailing Address
 Citizenship
 Phone Number or Email Address

    The public is also welcome to listen to the meeting by via Adobe 
Connect. Pre-registration is required by clicking the links below.
    WEB ID: May 9, 2018 (100 Seats) https://adobeconnect.cdc.gov/e9teo9x7k41/event/registration.html.
    WEB ID: May 10, 2018 (100 Seats) https://adobeconnect.cdc.gov/e2jt3r7tvlj/event/registration.html.
    Dial in number: 800-857-9618; Participant code: 6838980. (100 
Seats).

DATES: The meeting will be held on May 9, 2018, 10:00 a.m.-5:30 p.m., 
EDT and May 10, 2018, 8:30 a.m.-3:30 p.m., EDT.

ADDRESSES: Centers for Disease Control and Prevention (CDC), Global 
Communications Center, Building 19, Auditorium B3, 1600 Clifton Road 
NE, Atlanta, Georgia 30329.

FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Office of Science and 
Public Health Practice, Centers for Disease Control and Prevention, 
1600 Clifton Road NE, Mailstop D-44, Atlanta, Georgia 30329, Telephone: 
(404) 639-7450; Facsimile: (404) 471-8772; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: This Board is charged with providing advice and guidance 
to the Secretary, Department of Health and Human Services (HHS), the 
Assistant Secretary for Health (ASH), the Director, Centers for Disease 
Control and Prevention (CDC), and the Director, Office of Public Health 
Preparedness and Response (OPHPR), concerning strategies and goals for 
the programs and research within OPHPR, monitoring the overall 
strategic direction and focus of the OPHPR Divisions and Offices, and 
administration and oversight of peer review for OPHPR scientific 
programs. For additional information about the Board, please visit: 
https://www.cdc.gov/phpr/science/counselors.htm.
    Matters To Be Considered: The agenda will include discussions on 
Day one of

[[Page 13988]]

the meeting that will cover briefings and BSC deliberation on the 
following topics: Interval updates from the OPHPR Director and OPHPR 
Divisions and Offices; updates from the Biological Agent Containment 
working group; discussion of Industry, Private Sector, and Public 
Health Interactions Supporting Emergency Preparedness and Response; and 
Preparedness Updates from Liaison Representatives.
    Day two of the meeting will cover briefings and BSC deliberation on 
the following topics: OPHPR Office of Policy, Planning and Evaluation 
activities; CDC's Data Preparedness activities; Public Health System 
Perspectives on Hurricanes Response; and Excellence in Response 
Operations Initiative. Agenda items are subject to change as priorities 
dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-06546 Filed 3-30-18; 8:45 am]
 BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.